Peritoneal dialysis associated infections: An update on diagnosis and management
- PMID: 24175248
- PMCID: PMC3782204
- DOI: 10.5527/wjn.v1.i4.106
Peritoneal dialysis associated infections: An update on diagnosis and management
Abstract
Peritoneal dialysis (PD) is associated with a high risk of infection of the peritoneum, subcutaneous tunnel and catheter exit site. Although quality standards demand an infection rate < 0.67 episodes/patient/year on dialysis, the reported overall rate of PD associated infection is 0.24-1.66 episodes/patient/year. It is estimated that for every 0.5-per-year increase in peritonitis rate, the risk of death increases by 4% and 18% of the episodes resulted in removal of the PD catheter and 3.5% resulted in death. Improved diagnosis, increased awareness of causative agents in addition to other measures will facilitate prompt management of PD associated infection and salvage of PD modality. The aims of this review are to determine the magnitude of the infection problem, identify possible risk factors and provide an update on the diagnosis and management of PD associated infection. Gram-positive cocci such as Staphylococcus epidermidis, other coagulase negative staphylococcoci, and Staphylococcus aureus (S. aureus) are the most frequent aetiological agents of PD-associated peritonitis worldwide. Empiric antibiotic therapy must cover both gram-positive and gram-negative organisms. However, use of systemic vancomycin and ciprofloxacin administration for example, is a simple and efficient first-line protocol antibiotic therapy for PD peritonitis - success rate of 77%. However, for fungal PD peritonitis, it is now standard practice to remove PD catheters in addition to antifungal treatment for a minimum of 3 wk and subsequent transfer to hemodialysis. To prevent PD associated infections, prophylactic antibiotic administration before catheter placement, adequate patient training, exit-site care, and treatment for S. aureus nasal carriage should be employed. Mupirocin treatment can reduce the risk of exit site infection by 46% but it cannot decrease the risk of peritonitis due to all organisms.
Keywords: Catheter removal; Dialysis modality change; Exit site infection; Fungal peritonitis; Peritoneal dialysis; Peritonitis; Polymicrobial infection; Sclerosing encapsulating peritonitis; Tunnel infection.
Figures
Similar articles
-
The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.Adv Perit Dial. 2000;16:257-61. Adv Perit Dial. 2000. PMID: 11045306 Clinical Trial.
-
The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.Perit Dial Int. 2015 Dec;35(7):712-21. doi: 10.3747/pdi.2014.00206. Epub 2015 Jul 29. Perit Dial Int. 2015. PMID: 26224790 Free PMC article. Clinical Trial.
-
The honeypot study protocol: a randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients.Perit Dial Int. 2009 May-Jun;29(3):303-9. Perit Dial Int. 2009. PMID: 19458303 Clinical Trial.
-
Peritoneal Dialysis-Associated Peritonitis.Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1100-1105. doi: 10.2215/CJN.14631218. Epub 2019 May 8. Clin J Am Soc Nephrol. 2019. PMID: 31068338 Free PMC article. Review.
-
Catheter type, placement and insertion techniques for preventing catheter-related infections in chronic peritoneal dialysis patients.Cochrane Database Syst Rev. 2019 May 31;5(5):CD004680. doi: 10.1002/14651858.CD004680.pub3. Cochrane Database Syst Rev. 2019. PMID: 31149735 Free PMC article.
Cited by
-
Pathogens of peritoneal dialysis peritonitis: Trends from a single-center experience over 15 years.Kidney Res Clin Pract. 2020 Jun 30;39(2):221-227. doi: 10.23876/j.krcp.19.035. Kidney Res Clin Pract. 2020. PMID: 32449332 Free PMC article.
-
Development of acute kidney injury following pediatric cardiac surgery.Kidney Res Clin Pract. 2020 Sep 30;39(3):259-268. doi: 10.23876/j.krcp.20.053. Kidney Res Clin Pract. 2020. PMID: 32773391 Free PMC article. Review.
-
Peritoneal Dialysis Zoonotic Bacterial Peritonitis with Staphylococcus pseudintermedius.Case Rep Nephrol Dial. 2020 Jun 12;10(2):65-70. doi: 10.1159/000508126. eCollection 2020 May-Aug. Case Rep Nephrol Dial. 2020. PMID: 32775342 Free PMC article.
-
Ochrobactrum Peritonitis: Case Report and Literature Review.Cureus. 2020 Sep 21;12(9):e10564. doi: 10.7759/cureus.10564. Cureus. 2020. PMID: 33101810 Free PMC article.
-
A Case of Relapsing Peritoneal Dialysis-Associated Peritonitis by Dokdonella koreensis.Case Rep Infect Dis. 2018 Jul 5;2018:3820513. doi: 10.1155/2018/3820513. eCollection 2018. Case Rep Infect Dis. 2018. PMID: 30073100 Free PMC article.
References
-
- Bianchi P, Buoncristiani E, Buoncristiani U. Antisepsis. Contrib Nephrol. 2007;154:1–6. - PubMed
-
- Bender FH, Bernardini J, Piraino B. Prevention of infectious complications in peritoneal dialysis: best demonstrated practices. Kidney Int Suppl. 2006;70:S44–S54. - PubMed
-
- Macchini F, Valadè A, Ardissino G, Testa S, Edefonti A, Torricelli M, Luzzani S. Chronic peritoneal dialysis in children: catheter related complications. A single centre experience. Pediatr Surg Int. 2006;22:524–528. - PubMed
-
- Campos RP, Chula DC, Riella MC. Complications of the peritoneal access and their management. Contrib Nephrol. 2009;163:183–197. - PubMed
Publication types
LinkOut - more resources
Full Text Sources